Real-time enrollment status for this c. difficile infection clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:23 PM UTC
| NCT Number | NCT05330182 |
| Recruiting Status | Recruiting |
| Condition | C. Difficile Infection |
| Phase | PHASE2 |
| Target Enrollment | 375 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Lumen Bioscience, Inc. |
| Last Updated on CT.gov | February 10, 2026 (Feb 10, 2026) |
As of July 17, 2026: Clinical trial NCT05330182 is currently recruiting participants. This phase2 study for c. difficile infection is actively seeking new participants at 16 locations across the United States. The study is sponsored by Lumen Bioscience, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05330182 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05330182 was last updated Feb 10, 2026 (February 10, 2026). HelloStudys verifies this status automatically.